1. Response of Steroid-Refractory Acute GVHD to α1-Antitrypsin
A. Mario Marcondes, David Hockenbery, Marina Lesnikova, Charles A. Dinarello, Ann Woolfrey, Terry Gernsheimer, Mahmoud Loghman-Adham, David Gelmont, Barry Storer, John A. Hansen, H. Joachim Deeg 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 9, Pages (September 2016)
DOI: /j.bbmt
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Patient with steroid-refractory acute GVHD. (A) Sigmoidoscopic appearance before initiation of treatment with AAT. (B) After 7 doses of AAT (patient 4).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
AAT levels and clearance. (A) Plasma concentrations in 12 patients treated with 8 infusions of AAT. (B) Concentrations of AAT in stool before and during the course of AAT therapy. (C) Calculated AAT clearance on the basis of plasma and stool concentrations (see Methods).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Plasma TIM3 levels in patients in cohort 1 (solid line with black-circle data points) and cohort 2 (dotted line with white-square data points) over the duration of AAT treatment.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions

5. Figure 4
Proportion of regulatory T cells in peripheral blood. Shown are results for 5 healthy control subjects (black dots) and in 11 AAT-treated patients before (day 0) AAT, after the second dose of AAT (day 3), and upon completion of AAT therapy (last).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2016 American Society for Blood and Marrow Transplantation Terms and Conditions